Andrew John Nichols SEC EDGAR Filings (CIK 0001683749)

SEC EDGAR filings, ownership reports, and insider transactions for Andrew John Nichols.

Business address
C/O Catabasis Pharmaceuticals, Inc., One Kendall Square, Bldg 1400 E, Cambridge, MA, 02139
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Andrew John Nichols has filed 9 SEC EDGAR filings since 05 Oct 2016

Latest Filings

Recent SEC filings for Andrew John Nichols including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 03 Mar 2022 01 Mar 2022 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Jun 2021 02 Jun 2021 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 14 Feb 2020 12 Feb 2020 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 15 Feb 2019 13 Feb 2019 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 11 Sep 2018 07 Sep 2018 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 09 Feb 2018 08 Feb 2018 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 10 Feb 2017 09 Feb 2017 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 05 Oct 2016 03 Oct 2016 001-37467
3 Open 3 document View SEC filing for 3 FORM 3 - 05 Oct 2016 03 Oct 2016 001-37467

About this filer

Andrew John Nichols files with the SEC under CIK 0001683749. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages